Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950135-07-002966
Filing Date
2007-05-08
Accepted
2007-05-08 14:50:02
Documents
4
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b65352a1e10vkza.htm 10-K/A 90842
2 EX-10.44 LEASE AGREEMENT DATED OCTOBER 31, 2006 b65352a1exv10w44.txt EX-10.44 169149
3 EX-31.3 SECTION 302 CERTIFICATION OF CEO b65352a1exv31w3.htm EX-31.3 2497
4 EX-31.4 SECTION 302 CERTIFICATION OF CFO b65352a1exv31w4.htm EX-31.4 2508
  Complete submission text file 0000950135-07-002966.txt   266492
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31918 | Film No.: 07827732
SIC: 2836 Biological Products, (No Diagnostic Substances)